Overview

Intravesical Cidofovir for Hemorrhagic Cystitis

Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn how the drug cidofovir given as 1 dose directly into the bladder is absorbed by the body. Researchers also want to measure the amount of study drug in the body at different time points. The safety and tolerability of this drug will also be studied. Cidofovir is designed to fight certain viruses by blocking the virus cells from dividing.
Phase:
Phase 1
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborator:
Gilead Sciences
Treatments:
Cidofovir
Probenecid